Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease
Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 48
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
Milan Zimmermann, Kathrin Brockmann
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S183-S200
Open Access | Times Cited: 44
MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson’s disease
Danlei Wang, Hongling Gao, Qixiong Qin, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing
Michael R. Fiorini, Allison A. Dilliott, Rhalena A. Thomas, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 9
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Mujeeb Ur Rahman, Muhammad Bilal, Junaid Ali Shah, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1252-1252
Open Access | Times Cited: 36
DNA methylation as a mediator of genetic and environmental influences on Parkinson’s disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome
Samantha L. Schaffner, Michael S. Kobor
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 29
Large‐Scale Proteome Profiling Identifies Biomarkers Associated with Suspected Neurosyphilis Diagnosis
Jun Li, Jie Ma, Mingjuan Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 7
What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Rubén Fernández‐Santiago, Manu Sharma
Ageing Research Reviews (2022) Vol. 79, pp. 101648-101648
Open Access | Times Cited: 23
Parkinson’s disease therapy: what lies ahead?
Andreas Wolff, Nicolas U Schumacher, Dominik Pürner, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 793-820
Open Access | Times Cited: 15
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
Stefanie Lerche, Milan Zimmermann, Benjamin Röeben, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
Shuyu Zhang, Karina Dauer, Timo Strohäker, et al.
Brain Pathology (2023) Vol. 33, Iss. 5
Open Access | Times Cited: 11
An Overview of Epigenetic Changes in the Parkinson’s Disease Brain
Anthony Klokkaris, Anna Migdalska‐Richards
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6168-6168
Open Access | Times Cited: 4
Integrative approach of omics and imaging data to discover new insights for understanding brain diseases
Jong Hyuk Yoon, Hagyeong Lee, Dayoung Kwon, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 4
New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease
M H Liang, L. M. Chu, Zhenyu Yue
Movement Disorders (2025)
Closed Access
Tremor in the Age of Omics: An Overview of the Transcriptomic Landscape of Essential Tremor
Farah Aboasali, Charles-Etienne Castonguay, Miranda Medeiros, et al.
The Cerebellum (2025) Vol. 24, Iss. 2
Closed Access
Characterization of isolated human astrocytes from aging brain
Geidy E. Serrano, Sidra Aslam, Jessica E. Walker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Characterization of Isolated Human Astrocytes from Aging Brain
Geidy E. Serrano, Sidra Aslam, Jessica E. Walker, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3416-3416
Open Access
MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis
Diane Guévremont, Joyeeta Roy, Nicholas J. Cutfield, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network
Salvatore Pulcrano, Roberto De Gregorio, Claudia De Sanctis, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 48, pp. 8104-8125
Open Access | Times Cited: 6
Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease
Jae-Bong Kim, Yujeong Kim, Soo‐Jeong Kim, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
The discovery of phages in the Substantia Nigra and its implication for Parkinson's Disease
Yun Zhao, Changxian Xiong, Bingwei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Network approaches for omics studies of neurodegenerative diseases
Na Zhao, Zachary Quicksall, Yan W. Asmann, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells
Zhimin Wang, Jiating Yu, Dan Hao, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 5
The potential roles and mechanisms of Chitinase-3-like-1 in the pathogenesis of type 2-biased airway diseases
Yian Zhou, Zheng Liu, Yang Liu
Clinical Immunology (2023) Vol. 257, pp. 109856-109856
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top